{"id":"W2119413329","doi":"10.1158/1078-0432.ccr-06-2377","title":"A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Neutropenia; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Leukopenia; Population; Gastroenterology; Chemotherapy; Cancer; Phases of clinical research; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001630673,0.001332728,0.002371722,0.0004523391,0.0003107725,0.0006404772,0.0008147609,0.001402224,0.003988815],"category_scores_gemma":[0.001732919,0.00060207,0.0006896911,0.0003384133,0.001224675,0.0006992409,0.0002850735,0.002367804,0.0005786598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006296386,"about_ca_system_score_gemma":0.001111241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003635197,"about_ca_topic_score_gemma":0.0005929999,"domain_scores_codex":[0.9993206,0.0003620809,0.00004195882,0.0001334322,0.0000732902,0.00006872416],"domain_scores_gemma":[0.9988932,0.0003368757,0.0002539232,0.0001233426,0.00005092843,0.0003417297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9172038,0.04692642,0.0009628429,0.0002949308,0.0003629206,0.00003864841,0.00005801365,0.0004991096,0.01454323,0.0001230206,0.0004765486,0.01851055],"study_design_scores_gemma":[0.8113202,0.1847994,0.00146932,0.000008598139,0.0001075337,0.00003793945,0.000009437465,0.0004184885,0.001419511,0.00007163986,0.0003282592,0.000009514587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931652,0.0007068156,0.0007181587,0.0001828845,0.0001757112,0.003944098,0.0003312492,0.00007009815,0.0007057541],"genre_scores_gemma":[0.984738,0.0009284434,0.003176665,0.0007974938,0.0002952621,0.007409121,0.0007254526,0.00002271289,0.001906764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003988815,"threshold_uncertainty_score":0.01334387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3282812492929229,"score_gpt":0.6418834965688445,"score_spread":0.3136022472759216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}